Abbott Looks to Consumer for Growth - WSJ.com. Related articles Gilead Shares Rise on Hepatitis C Treatment (minyanville.com) Hep C drugs bring high cure rates in trial (todayonline.com) Abbott's three oral hepatitis C drugs produce high cure rates in trial (medcitynews.com) Abbot Holding Steady For Long-Term Investments (seekingalpha.com) Big Corporate Breakups In 2011 (forbes.com) Abbott … Continue reading Abbott Looks to Consumer for Growth
Tag: Gilead Sciences
Apple Science Profiles – Vertex Pharmaceuticals
Apple - Science - Profiles - Vertex Pharmaceuticals. Vertex uses Macs. Related articles Safety Can't Be an Afterthought (fool.com) Vertex (VRTX) Report Positive Data from Viral Kinetic of ALS-2200 in HCV Patients (streetinsider.com) Big Pharma + Big Failure = Big Punishment (dailyfinance.com) U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts (xconomy.com) Vertex … Continue reading Apple Science Profiles – Vertex Pharmaceuticals
Vertex: Planning Trial Supplies Using Tourtellotte Software
Vertex: Planning Trial Supplies Using Tourtellotte Software - Bio-IT World. Related articles A Non-Earnings Boost for Vertex (fool.com) Why You Should Be Bullish On Vertex Now (seekingalpha.com) Vertex surges as rival hep C contender plays catch-up in clinic (fiercebiotech.com) Bristol-Myers' Hepatitis Stumble Boosts Gilead, Vertex (minyanville.com) Vertex Wins EU Approval for Cystic Fibrosis Drug … Continue reading Vertex: Planning Trial Supplies Using Tourtellotte Software
You must be logged in to post a comment.